Declines in serum uric acid level after catheter ablation of atrial fibrillation.
Daisetsu AoyamaHiroyasu UzuiTakayuki SekiharaTomoya EguchiKanae HasegawaToshihiko TsujiTatsuhiro KataokaMoeko NagaoShota KakehashiMoe MukaiTakayoshi AikiJunya YamaguchiYuichiro ShiomiNaoto TamaYoshitomo FukuokaKentaro IshidaHiroshi TadaPublished in: Heart and vessels (2022)
Catheter ablation for AF patients significantly improved serum UA levels without obvious influences of heart failure, renal function, or inflammation, suggesting that AF ablation may be effective for AF patients with hyperuricemia. Trial registration The study was approved by the Research Ethics Committee of University of Fukui (no. 20210132) and clinical trial registration (UMIN000044669).
Keyphrases
- atrial fibrillation
- catheter ablation
- uric acid
- left atrial
- heart failure
- left atrial appendage
- clinical trial
- oral anticoagulants
- direct oral anticoagulants
- end stage renal disease
- metabolic syndrome
- percutaneous coronary intervention
- chronic kidney disease
- study protocol
- phase ii
- newly diagnosed
- ejection fraction
- public health
- phase iii
- peritoneal dialysis
- big data
- randomized controlled trial
- double blind
- venous thromboembolism
- coronary artery disease
- machine learning
- mitral valve